(Q50563212)

15 March 2018

title

Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial (English)

1 reference

15 March 2018

1 reference

1

1 reference

15 March 2018

Hans H Storm

series ordinal

2

1 reference

15 March 2018

author name string

Hansen JF

series ordinal

3

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

15 March 2018

American Journal of Cardiology

published in

1 reference

15 March 2018

volume

83

1 reference

15 March 2018

issue

9

1 reference

15 March 2018

page(s)

1419-22, A9

1 reference

15 March 2018

Calcium-channel blockade and incidence of cancer in aged populations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Calcium-channel blockers and risk of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Calcium Channel Blockers and the Risk of Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Cancer risk in users of calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Cohort study analysis with a FORTRAN computer program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

The estimation and significance of the logarithm of a ratio of frequencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

7 January 2021

Apoptosis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Calcium channel blockers for hypertension: dissecting the evidence for adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Calcium channel blockers and the risk of cancer: a preclinical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900113-7

10.1016/S0002-9149(99)00113-7

7 January 2021

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018